Case Name: NAPRO BIOTHERAPEUTICS, INC. (now known as Tapestry Pharmaceuticals, Inc.) and Maybe Pharma (USA) Inc. (now known as Faulding Pharmaceutical Co.), Plaintiffs-Appellees, v. MYLAN LABORATORIES INC., Mylan Pharmaceuticals, Inc. and UDL Laboratories, Inc., Defendants-Appellants
Court: United States Court of Appeals for the Federal Circuit
Jurisdiction: United States
Decision Date: 2004-08-04
Citations: 104 F. App'x 742
Docket Number: No. 04-1170
Parties: NAPRO BIOTHERAPEUTICS, INC. (now known as Tapestry Pharmaceuticals, Inc.) and Maybe Pharma (USA) Inc. (now known as Faulding Pharmaceutical Co.), Plaintiffs-Appellees, v. MYLAN LABORATORIES INC., Mylan Pharmaceuticals, Inc. and UDL Laboratories, Inc., Defendants-Appellants.
Judges: 
Reporter: West's Federal Appendix
Volume: 104
Pages: 742–742

Head Matter:
NAPRO BIOTHERAPEUTICS, INC. (now known as Tapestry Pharmaceuticals, Inc.) and Maybe Pharma (USA) Inc. (now known as Faulding Pharmaceutical Co.), Plaintiffs-Appellees, v. MYLAN LABORATORIES INC., Mylan Pharmaceuticals, Inc. and UDL Laboratories, Inc., Defendants-Appellants.
No. 04-1170.
United States Court of Appeals, Federal Circuit.
Aug. 4, 2004.
George C. Lombardi, Principal Attorney, James F. Hurst, Alice L. Riechers, David J. Doyle, of Counsel, Winston & Strawn, Kristen G. Cowan, of Counsel, Chicago, IL, Robert M. Linn, of Counsel, Cohen & Grigsby, Pittsburgh, PA, for Plaintiffs-Appellees.
E. Anthony Figg, Principal Attorney, Glenn E. Karta, Martin M. Zoltick, Sharon L. Davis, of Counsel, Rothwell, Figg, Washington, DC, for Defendants-Appellants.

Opinion:
ON MOTION
ORDER
Upon consideration of the parties' joint motion to voluntarily dismiss this appeal, due to settlement,
IT IS ORDERED THAT:
(1) The motion is granted.
(2) Each side shall bear its own costs.